DRAP
The new article provides an overview of the critical responsibilities of the parties involved in recalls associated with therapeutic products, as well as additional communication details to ensure the vitally important safety information is duly delivered to the affected parties.
DRAP
The new article highlights certain specific aspects related to the recalls the parties responsible for medical devices should initiate once it is identified that such products may pose risks to public health.
DRAP
The new article highlights the aspects of clinical research concerning the products intended to be marketed and used in Pakistan.
DRAP
The new article describes in detail the regulatory approach to be followed when reviewing the applications related to clinical investigations to be conducted in Pakistan.
DRAP
The new article highlights the critical points related to the application process, outlining the key steps to be taken when applying for approval in a clinical investigation.
DRAP
The new article describes in detail the key responsibilities of the parties involved in clinical research.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
